Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis.
Citation: Critical Care (London, England). 21(1):130, 2017 Jun 05PMID: 28583148Institution: MedStar Washington Hospital CenterDepartment: Medicine/Pulmonary-Critical CareForm of publication: Journal ArticleMedline article type(s): LetterSubject headings: *Anti-Bacterial Agents/ec [Economics] | *Health Care Costs/sn [Statistics & Numerical Data] | *Hospitalization/ec [Economics] | *Pneumonia/dt [Drug Therapy] | *Sepsis/dt [Drug Therapy] | Acinetobacter baumannii/py [Pathogenicity] | Anti-Bacterial Agents/tu [Therapeutic Use] | Cohort Studies | Hospitalization/sn [Statistics & Numerical Data] | Humans | Pneumonia/ec [Economics] | Sepsis/ec [Economics] | Survivors/sn [Statistics & Numerical Data] | Time FactorsYear: 2017Local holdings: Available online from MWHC library: 1997 - present (after 1 year)ISSN:- 1364-8535
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 28583148 | Available | 28583148 |
Available online from MWHC library: 1997 - present (after 1 year)
English